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Abstract
Dysmenorrhea is highly prevalent and may increase women’s risk for developing other chronic 
pain conditions. Although it is highly variable, symptom-based dysmenorrhea phenotypes have not 
been identified. The study aims were to identify symptom-based dysmenorrhea phenotypes and 
examine their relationships with demographic and clinical characteristics. In a cross-sectional 
study, 762 women with dysmenorrhea rated severity of 14 dysmenorrhea-related symptoms. Using 
latent class analysis, we identified three distinctive phenotypes. Women in the “mild localized 
pain” phenotype (n=202, 26.51%) had mild abdominal cramps and dull abdominal pain/
discomfort. Women in the “severe localized pain” phenotype (n=412 54.07%) had severe 
abdominal cramps. Women in the “multiple severe symptoms” phenotype (n=148, 19.42%) had 
severe pain at multiple locations and multiple gastrointestinal symptoms. Race, ethnicity, age, and 
comorbid chronic pain conditions were significantly associated with phenotypes. Identification of 
these symptom-based phenotypes provides a foundation for research examining genotype-
phenotype associations, etiologic mechanisms, and/or variability in treatment responses.
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Dysmenorrhea is a prevailing pain condition affecting 45% to 95% of women of 
reproductive age (Iacovides, Avidon, & Baker, 2015). On a monthly basis, it contributes to 
lost work/study hours, reduced physical activity, and lower quality of life (Iacovides et al., 
2015). Commonly occurring with other chronic pain conditions (e.g., irritable bowel 
syndrome, noncyclic pelvic pain), dysmenorrhea can exacerbate other pain conditions 
(Giamberardino et al., 2010) or increase women’s risk for future chronic pain (Berkley, 
2013; Iacovides et al., 2015; Westling, Tu, Griffith, & Hellman, 2013). Given its significant 
short- and long- term impact on women’s lives, scientists have called for more research into 
dysmenorrhea mechanisms and treatment options (Berkley, 2013; Iacovides et al., 2015).
Symptom–based dysmenorrhea phenotypes have not been identified, which impedes 
mechanistic investigation and precision-based treatment development. Based on the National 
Institute of Health Symptom Science Model, phenotypic characterization is fundamental to 
discovering biomarkers and illuminating precision-based symptom management (Cashion & 
Grady, 2015). A symptom-based phenotype is a subgroup of individuals with a given 
condition who share similar symptom characteristics. Symptom-based phenotypes exist in 
other groups. For example, among women experiencing menopausal symptoms, five 
different symptom phenotypes were identified that varied in the type and severity of 
symptoms experienced (Woods et al., 2016). Such phenotypes can be valuable in 
understanding mechanisms underlying symptoms (Tu & As-Sanie, 2016; Turk, 2005), 
linking genotypes to phenotypes (Anttila et al., 2006), differentiating treatment effects 
(Turk, 2005), and tailoring treatments based on phenotypes (Turk, 2005).
Earlier studies suggested that women’s dysmenorrhea symptoms vary. For example, women 
have described variability in whether they experience gastrointestinal symptoms along with 
painful cramps (Heitkemper, Shaver, & Mitchell, 1988), and whether they experience 
menstrual pain as severe or excruciating (Ju, Jones, & Mishra, 2014). It is unclear, however, 
if women form distinctive subgroups based on dysmenorrhea symptom experience.
Factors that differentiate phenotypes are also unknown and these may include demographic 
and clinical variables. For demographic variables, older age and higher education levels have 
been related to lower dysmenorrhea prevalence (Ju et al., 2014; Woods, Most, & Dery, 
1982). Ethnicity may also have an impact on the dysmenorrhea experience. In a pilot 
comparative study, Chinese women reported milder menstrual pain than Australian women 
(mainly Caucasian) (Zhu et al., 2010). Years with dysmenorrhea could affect perceived 
symptom severity.
Clinical characteristics are also important potential factors to consider. Clinically, 
dysmenorrhea is commonly classified into two types: primary, when symptoms occur in 
absence of underlying pathology; and secondary, when symptoms are caused by underlying 
pathology (e.g., endometriosis and uterine fibroids) (International Association for the Study 
of Pain (IASP) Taxonomy Working Group, 2011). It is commonly believed that 
dysmenorrhea symptoms are more severe among women with pelvic pathology than women 
without pelvic pathology. Research findings, however, have been equivocal. While some 
research suggests women with endometriosis are more likely to report severe menstrual pain 
than those without (Apostolopoulos, Alexandraki, Gorry, & Coker, 2016), others suggest 
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women with and without pelvic pathology experience similar dysmenorrhea symptoms 
(Nguyen, Humphrey, Kitchen, Rehman, & Norquist, 2015), and the symptom severity is not 
well correlated with pathology (Gruppo Italiano per lo Studio dell’Endometriosi, 2001). In 
addition to this pathology-based clinical classification, comorbid pain conditions are 
important to consider given their high co-occurrence with dysmenorrhea (Berkley, 2013; 
Giamberardino et al., 2010; Iacovides et al., 2015; Westling et al., 2013).
In this study, our aims were to (1) identify symptom-based dysmenorrhea phenotypes and 
(2) investigate their relationships with demographic and clinical variables.
Methods
Design and Participants
This was a cross-sectional descriptive study. Using a web-based survey, data were collected 
from 762 women with dysmenorrhea in the United States (Chen, Kwekkeboom, & Ward, 
2016). The University Health Sciences Institutional Review Boards approved this 
anonymous survey study and granted a waiver of written informed consent. Survey 
completion implied informed consent. Data collection occurred during January and February 
of 2015.
Women eligible for the study were (1) at least 18 years old, (2) living in the United States, 
(3) able to read and write in English, and (4) self-identified as having had dysmenorrhea 
symptoms in the last 6 months. Participants were recruited through established online survey 
panels (Qualtrics, UT). Those online panels consisted of individuals who were willing to be 
contacted for internet surveys. Participants of the panels are usually recruited by banner ads 
on websites, direct mail or emails, or by word of mouth (Baker et al., 2010). Online survey 
panels have been used in large studies, including the development of Patient-Reported 
Outcome Measurement Information System (PROMIS®) funded by the National Institutes 
of Health (Liu et al., 2010) and flu vaccination coverage study sponsored by the Centers for 
Disease Control and Prevention (Centers for Disease Control and Prevention (CDC), 2013). 
The panel provider informed us that panel registrants were of diverse race/ethnicity, thus, we 
did not make a special effort to oversample a particular race/ethnicity. The panel provider 
emailed study invitations to panel registrants who met the first three eligibility criteria. 
Interested women were directed to the survey website, and a screening question further 
identified those who met the fourth eligibility criterion. The screening question read “Some 
women experience abdominal cramps and other symptoms just before or during a menstrual 
period (for example, low back pain, nausea, vomiting, change in the number and type of 
bowel movements, change in appetite). The medical term for these symptoms is 
“dysmenorrhea” (pronounced dis-men-uh-ree-uh). Think about the last 6 months. During 
this time, have you had any of these dysmenorrhea symptoms?” Among 1384 women who 
responded to the screening question, 977 women indicated that they had experienced 
symptoms (i.e., met the fourth eligibility criterion) and were invited to complete the study. 
Participants received compensation ($3.50 USD), as arranged with the panel provider. To 
safeguard data quality, we excluded the following respondents before data analysis: 
respondents who clicked the same answer every time; respondents who spent less than one-
third the median time to complete the survey; and respondents who failed one or more 
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attention filters that were embedded in the survey. Attention filters were questions that 
required a specific response, which was provided within the question (e.g., “mark answer 
B”). Among the 977 women who met eligibility criteria, 762 (78.0%) completed the survey 
with valid responses. The median time for survey completion was 14 minutes. Details on the 
flow of participants through the study are published elsewhere (Chen et al., 2016).
Measures
Dysmenorrhea Symptoms—Participants rated the severity and bother of 14 
dysmenorrhea-related symptoms (listed in Table 1). The choice of symptoms was based on a 
review of dysmenorrhea measures (Chen, Kwekkeboom, & Ward, 2015). Instructions for 
each symptom were: “Think about the past 6 months. Before or during your period, how 
severe was [symptom] usually? Before or during your period, how bothersome was 
[symptom] usually?” Participants rated severity and bother on 0 “not present/no bother” to 
10 “extremely severe/extreme bother” scales. Because severity and bother had significant 
correlation (r’s = 0.92 to 0.99; p’s < 0.001), we used only severity scores in the current data 
analysis. Each severity rating was further grouped into one of four categories based on 
established cut-offs: no symptom (0), mild (1–4), moderate (5–6), and severe (7–10) 
(Oldenmenger, de Raaf, de Klerk, & van der Rijt, 2013; Serlin, Mendoza, Nakamura, 
Edwards, & Cleeland, 1995).
Demographics and Clinical Characteristics—As potential covariates for subgroup 
membership, we collected data on the demographic and clinical characteristics that we 
identified in the literature (Apostolopoulos et al., 2016; Berkley, 2013; Ju et al., 2014; Zhu et 
al., 2010). Women provided demographic information including current age, age at 
dysmenorrhea symptom onset, race, ethnicity, and highest level of education. By subtracting 
symptom-onset age from chronological age, we calculated “years with dysmenorrhea”.
Women provided relevant clinical information including history of gynecological conditions 
that are related to secondary dysmenorrhea and comorbid chronic pain conditions. 
Specifically, participants were asked if a health care provider had ever diagnosed them with 
any of the following conditions: endometriosis, adenomyosis, uterine fibroids/myomas, and 
pelvic inflammatory disease. Participants were also asked to select if they had any of the 
following common chronic pain conditions: back pain, irritable bowel syndrome, migraine 
headaches, non-migraine headaches, fibromyalgia, neck pain, pelvic pain occurring outside 
of the menstrual period, and painful sexual intercourse (dyspareunia).
Statistical Analysis
We used all responses that were determined as valid (N=762). Descriptive statistics were 
used to summarize demographics and clinical characteristics. Latent class analysis (LCA) 
was performed to identify symptom-based phenotypes. LCA is an established statistical 
method that is used to find subgroups or phenotypes (i.e., latent classes) of individuals based 
on response patterns that are not directly observed (Hagenaars & McCutcheon, 2002). In 
LCA analysis, women with similar dysmenorrhea symptom profiles were classified into the 
same subgroup based on conditional probabilities. Specifically, women were classified based 
on severity (no, mild, moderate, severe) of the 14 dysmenorrhea-related symptoms.
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The final number of phenotypes (i.e., latent classes) was determined based on model fit and 
model usefulness. Model fit was determined by inspecting values of Bayesian information 
criterion (BIC, lower value, better fit) and Akaike information criterion (AIC, lower value, 
better fit). Model usefulness was determined by the measure of entropy (>0.8 suggesting 
satisfactory classification of individual participants) and interpretability of the latent class 
solution. Among solutions with entropy values above 0.8 (see Table 2), we chose the 
solution with lowest AIC (i.e., three-class solution), as opposed to the solution with lowest 
BIC (i.e., two-class solution) because models selected based on the BIC tend to be overly 
simplified (Woods et al., 2016). The three-class solution represented a finer and more 
interpretable classification of individual participants.
The interpretation of each phenotype was based on examining posterior probabilities. 
Specifically, for each symptom, the sum of Manhattan distances between the posterior 
probabilities and 0.25 was calculated. When the sum is at least 0.4, the symptom was 
unevenly distributed across the four severity categories (none, mild, moderate, severe). For 
these symptoms, the severity category with the greatest probability was used to derive an 
interpretation of the latent class.
To investigate associations between phenotypes and covariates (i.e., demographic and 
clinical characteristics), we used the one-step latent class model estimation approach, in 
which, the phenotypes were estimated and regressed on covariates simultaneously (Bolck, 
Croon, & Hagenaars, 2004). This one-step approach overcomes the biased-estimation issue 
associated with the traditional three-step approach (Bolck et al., 2004). Asian, Mixed races, 
and those without race information were combined into a category of “Other” race for 
modeling. Because having a large number of covariates would decrease the precision of the 
parameter estimates, we reduced the number of covariates by grouping chronic pain 
conditions. We used the following categories: back pain, neck pain, headaches (including 
migraine and non-migraine headaches), irritable bowel syndrome, fibromyalgia, and pelvic 
pain other than dysmenorrhea (including pelvic pain occurring outside of menstrual period 
and dyspareunia/painful sexual intercourse). These categories are based on the diagnostic 
clusters for population pain research recommended by the United States National Pain 
Strategy (Interagency Pain Research Coordinating Committee, 2015). In addition, only 
covariates with prevalence higher than 5% were entered into the model, as less frequent 
covariates would result in unstable and imprecise estimates. Multicollinearity issues were 
not observed among covariates. The variance inflation factor (VIFs) values were all below 
10, which indicated that the covariates were not highly inter-correlated. Strengths and 
directions of associations between covariates and latent class membership were quantified 
with relative risk ratios (RRR) and 95% confidence intervals. MPlus (V6.1) was used for the 
latent class analysis. Other analyses were conducted using SAS/STAT (V9.4) software 
(Cary, NC).
Results
Sample Characteristics
The mean age of the sample was 34.1 years (SD =6.6, Range: 18–49). The majority were 
White (73.4% White, 13.1% African American, 4.7% Asian, 2.2% mixed race) and non-
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Hispanic (89.8%). Slightly more than half (53.7%) had an Associate Degree or higher 
education. The majority (69.7%) had at least one comorbid chronic pain condition, with the 
most frequent comorbid pain conditions being lower back pain (46.9%), migraine headaches 
(29.8%), non-migraine headaches (23.9%), neck pain (17.3%), irritable bowel syndrome 
(12.9%), painful sexual intercourse/dyspareunia (11.0%), and pelvic pain occurring outside 
of menstruation (10.5%). Some (18.0%) reported being diagnosed with a gynecological 
condition that could have contributed to secondary dysmenorrhea, including uterine fibroids 
(7.7%), endometriosis (5.6%), pelvic inflammatory disease (3.4%), adenomyosis (0.8%), 
and other miscellaneous conditions (3.9%). On average, women reported 6.0 (SD=2.5) 
symptoms (range 1 to 14). The five most commonly reported symptoms were abdominal 
cramps (86.1%), low back pain (75.2%), bloating (73.9%), dull abdominal pain or 
discomfort (65.0%), and headache or migraine (61.2%). The five least commonly reported 
symptoms were vomiting (7.2%), fewer bowel movements than usual (9.1%), pain in the 
upper thighs (21.5%), constipation (22.7%), and reduced appetite (27.0%).
Identification of Symptom-based Phenotypes
Three distinct phenotypes of women with dysmenorrhea were identified as shown in Table 1. 
Phenotype 1 (n= 202, 26.5% of the total sample) was named “mild localized pain” as 
women in this group reported mild abdominal cramps and dull abdominal pain/discomfort, 
and few other symptoms. Phenotype 2 (n= 412, 54.1%) was named “severe localized pain” 
as women in this group reported severe abdominal cramps. Some participants in this 
phenotype also experience a few other symptoms such as low back pain, headache or 
migraine, and bloating. However, those symptoms were about evenly distributed across the 
severity categories (i.e., none, mild, moderate, severe). These symptoms, thus, did not 
characterize this phenotype. Phenotype 3 (n=148, 19.4%) was named “multiple severe 
symptoms” as women in this group reported severe pain at multiple locations (including 
abdominal cramps, dull abdominal pain/discomfort, lower back pain, headaches, and aches 
all over) and multiple gastrointestinal symptoms (including bloating, nausea, diarrhea, and 
more bowel movements than usual). The pain at multiple locations and gastrointestinal 
symptoms were all distributed toward the severe category. These symptoms, thus, did 
characterize Phenotype 3. The five least commonly reported symptoms (vomiting, fewer 
bowel movements than usual, pain in the upper thighs, constipation, and reduced appetite) 
did not discriminate across the phenotypes.
Relationship Between Phenotypes and Demographic and Clinical Characteristics
Age, race/ethnicity, years with dysmenorrhea, and certain comorbid chronic pain conditions 
were significantly associated with phenotype (see Table 3). Relative to the “mild localized 
pain” phenotype, women in the “severe localized pain” phenotype were more likely to have 
migraine or non-migraine headaches (RRR=1.99, p=0.019). Relative to the “mild localized 
pain” phenotype, women in the “multiple severe symptoms” phenotype were significantly 
more likely to be older (RRR=1.10, p=0.001), Black (RRR=3.68, p=0.004), Hispanic 
(RRR=4.23, p=0.007), have fewer years with dysmenorrhea (RRR=.95, p=0.014), have 
migraine or non-migraine headaches (RRR=3.08, p<0.001), have neck pain (RRR=2.23, 
p=0.037), or have pelvic pain other than dysmenorrhea (i.e., pelvic pain outside of 
menstruation or dyspareunia) (RRR=2.74, p=0.008). Compared to women in the “severe 
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localized pain” phenotype, women in the “multiple severe symptoms” phenotype were more 
likely to be older (RRR=1.06, p=0.014), Black (RRR=2.72, p=0.005), Hispanic (RRR=2.76, 
p=0.015), have fewer years with dysmenorrhea (RRR=.96, p=0.042), have neck pain 
(RRR=2.09, p=0.015), or have pelvic pain other than dysmenorrhea (RRR=2.90, p<0.001). 
Diagnosis of endometriosis or uterine fibroids were not significantly associated with any 
phenotype. Because race data was missing for some participants (n=50, 6.56%), we repeated 
analyses excluding these cases, but findings were unchanged. Table 4 provides a descriptive 
summary of the demographic and clinical characteristics by three phenotypes.
Discussion
The identified phenotypes support dysmenorrhea as a heterogeneous condition where 
symptom severity varies (Ju et al., 2014) and some women experience multiple symptoms 
(Heitkemper et al., 1988). Our study makes a new contribution in empirically identifying 
distinct symptom-based phenotypes to elucidate this heterogeneity.
While previous studies have identified relationships between demographics and 
dysmenorrhea prevalence (Ju et al., 2014; Woods et al., 1982), our study differed in that we 
identified relationships between demographics and phenotypes. Adding to the limited 
literature on race/ethnicity differences in dysmenorrhea symptomology (Zhu et al., 2010), 
we found that Black women and Hispanic women were more likely to be in the “multiple 
severe symptom” phenotype. Black and Hispanic women also have earlier menarche than 
White women (Wu, Mendola, & Buck, 2002); Black women also have higher heavy 
bleeding episodes than White women (Harlow & Campbell, 1996). Race and ethnicity are 
also associated with prevalence, progression, and outcomes of various pain conditions 
(Campbell & Edwards, 2012). Clinicians should be aware of the potential race and ethnicity 
differences in dysmenorrhea and improve treatment outcomes for minority patients. 
Although older age is associated with lower dysmenorrhea prevalence (Ju et al., 2014), we 
found that older age was associated with the “multiple severe symptoms” phenotype. One 
explanation may be increased pain sensitivity with aging (Yezierski, 2012). However, the 
age difference (<2.2 years) and effect size estimates (RRRs<1.1) were small, and it remains 
unclear whether the age difference is clinically meaningful. To reduce potential race/
ethnicity/age disparities in dysmenorrhea, it is essential to elucidate the biopsychosocial 
mechanisms underlying these associations.
Findings support the growing literature linking dysmenorrhea to other pain conditions 
(Berkley, 2013; Giamberardino et al., 2010; Iacovides et al., 2015; Westling et al., 2013). 
The novelty in our findings is that the likelihood of having comorbid pain differed based on 
phenotypes. The high prevalence of comorbid pain in the “multiple severe symptoms” 
phenotype could be explained by persistent central sensitization, because a heightened 
sensitivity of the central nervous system (CNS) characterizes many chronic pain syndromes 
(Woolf, 2011). We did not find significant association between phenotypes and certain 
gynecological conditions. Wide confidence intervals were noted likely due to few 
participants reporting endometriosis or uterine fibroids diagnosis (n= 43 and 59, 
respectively) and/or lack of laparoscopic confirmation of some diagnosis. Previous research 
also showed little association between pelvic pathology and symptomatology (Fedele, 
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Bianchi, Bocciolone, Di Nola, & Parazzini, 1992; Gruppo Italiano per lo Studio 
dell’Endometriosi, 2001). Therefore, it can be problematic to assume pelvic pathologies as 
the primary determinant of dysmenorrhea symptomology.
We acknowledge study limitations. First, because the literature on covariates of 
dysmenorrhea symptomology is limited, we may have omitted factors that discriminate 
phenotypes. Future research could consider biopsychosocial factors that are known to impact 
pain and central pain mechanisms (e.g., genetics, estrogen, inflammation, sleep, and 
psychological distress) (Phillips, & Clauw, 2011). Second, there could be recall bias in 
survey responses. Third, due to logistical challenges in parental consent, we did not include 
adolescents younger than 18. Fourth, there could be self-selection bias and coverage bias and 
associated with our sampling method. Only internet users were surveyed. Researchers using 
other sampling methods can further assess consistency and reproducibility of the findings.
Our findings have implications for future research. Findings may provide precise and 
individualized insights into the mechanistic underpinnings of dysmenorrhea, as phenotypes 
may involve different mechanisms. A main etiology of dysmenorrhea is elevated 
prostaglandins (Dawood, 2006; Iacovides et al., 2015). However, other mechanisms may 
also underlie dysmenorrhea, such as central sensitization that involves hypersensitivity to 
pain in multiple sites (Iacovides et al., 2015). Severe central sensitization may particularly 
affect the “multiple severe symptoms” phenotype, but needs further research. Similarly, 
genetic polymorphisms are linked to dysmenorrhea (Jones et al., 2016) and may explain 
specific phenotypes. Future research on biomarkers, genetics, and symptoms could provide 
insight into the mechanisms underlying phenotypes.
Our findings have relevance for research on personalizing, enhancing, and developing novel 
dysmenorrhea treatments. Individuals with different phenotypes may respond to the same 
treatment differently, as shown in depression (Uher et al., 2012). It is currently unclear if 
prostaglandin inhibitors work equally in women with localized pain and women with 
widespread pain and gastrointestinal symptoms. Incorporating phenotypes as a potential 
moderator of intervention effects will allow us to determine what treatment is effective for 
whom. Similarly, the “multiple severe symptoms” phenotype may require more intensive, 
comprehensive, or novel treatments that address multiple symptoms. For example, if strong 
CNS involvement is confirmed in this group, novel use of treatments targeting central 
sensitization (e.g., gabapentin and tricyclic antidepressants) (Woolf, 2011) may be promising 
especially for women refractory to conventional treatment. Instead of treating women as a 
homogeneous group, treatments could be matched to specific phenotypes to improve cost-
effectiveness.
Our findings have implications for clinical practice. First, it is essential to acknowledge 
symptom heterogeneity to accurately assess and treat women with dysmenorrhea. Second, 
clinicians should be mindful of the associations between dysmenorrhea and other pain 
conditions. It is important to screen for dysmenorrhea among women with chronic pain, and 
vice versa, to screen for chronic pain among women with significant dysmenorrhea 
symptom burden. Effective dysmenorrhea treatment has been shown to decrease pain and 
symptoms from other organs (Giamberardino et al., 2010). Third, it is vital to take a 
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symptom-based rather than a solely pathology-based approach in managing dysmenorrhea to 
avoid discounting symptomatology in those without pelvic pathology. Traditional 
dysmenorrhea classification based on pathology is inadequate (Stratton, Khachikyan, Sinaii, 
Ortiz, & Shah, 2015; Tu & As-Sanie, 2016). Growing evidence supports that women with 
pelvic pain likely share common symptom mechanisms, regardless of pathology (Tu & As-
Sanie, 2016).
In conclusion, we have identified three symptom-based dysmenorrhea phenotypes and 
explored demographic and clinical correlates. This phenotype characterization is a 
foundational step for conducting research designed to uncover etiologic mechanisms 
underlying women’s variability in dysmenorrhea symptoms and, ultimately, to guide 
precision-based treatments.
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Table 2
Latent Class Analyses Model Fit and Usefulness Indices
Number of Classes Log Likelihood BIC AIC Entropy
1 −19050.43 38552.10 38236.86
2 −9891.71 20433.74 19979.42 0.82
3 −9722.36 20466.66 19752.73 0.81
4 −9574.496 20542.541 19568.99 0.79
Note: BIC: Bayesian information criterion; AIC: Akaike information criterion. The model of selection is bolded.
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Table 4
Demographic and Clinical Characteristics by Symptom-based Phenotypes (N=762)
“Mild-localized pain” phenotype
(n=202)
“Severe localized 
pain” phenotype
(n=412)
“Multiple severe 
symptoms” phenotype
(n=148)
Age (y)* 33.1 ± 6.4 34.2 ± 6.7 35.3 ± 6.3
Years with Dysmenorrhea* 16.6 ± 7.5 16.6 ± 8.3 15.9 ± 8.7
Race
 Black 20 (9.9) 50 (12.1) 30 (20.3)
 White 159 (78.7) 310 (75.2) 90 (60.8)
Other 23 (11.4) 52 (12.6) 28 (18.9)
Hispanic 12 (5.9) 37 (9.0) 29 (19.6)
Education
 Less than Associate Degree 82 (40.6) 189 (45.9) 82 (55.4)
 Associate Degree or More 120 (59.4) 223 (54.1) 66 (44.6)
Back Pain 76 (37.6) 182 (44.2) 99 (66.9)
Irritable Bowel Syndrome 14 (6.9) 48 (11.7) 36 (24.3)
Migraine Headaches 33 (16.3) 122 (29.6) 72 (48.6)
Non-Migraine Headaches 29 (14.4) 96 (23.3) 57 (38.5)
Fibromyalgia 5 (2.5) 16 (3.9) 18 (12.2)
Neck Pain 21 (10.4) 58 (14.1) 53 (35.8)
Pelvic Pain Occurring Outside of Menstrual Period 6 (3.0) 33 (8.0) 41 (27.7)
Dyspareunia/Painful Sexual Intercourse 17 (8.4) 34 (8.3) 33 (22.3)
Endometriosis 2 (1.0) 25 (6.1) 16 (10.8)
Adenomyosis 2 (1.0) 3 (0.7) 1 (0.7)
Uterine Fibroids/Myomas 5 (2.5) 34 (8.3) 20 (13.5)
Pelvic Inflammatory Disease 4 (2.0) 12 (2.9) 10 (6.8)
Note.
*
Data are mean ± standard deviation (SD). All other data are n (%).
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